Legal & General Group PLC Royalty Pharma PLC Transaction History

Legal & General Group PLC

$431 Billion
Q3 2025

A detailed history of Legal & General Group PLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Legal & General Group PLC holds 2,822,566 shares of RPRX stock, worth $111 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,822,566

Previous 2,719,093 3.81%

Holding current value

$111 Million

Previous $98 Million 1.65%

% of portfolio

0.02%

Previous 0.03%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$34.9 - $37.91 $3.61 Million - $3.92 Million	103,473 Added 3.81%	2,822,566 $99.6 Million
Q2 2025 Aug 12, 2025	SELL	$30.85 - $36.14 $2.83 Million - $3.32 Million	-91,787 Reduced 3.27%	2,719,093 $98 Million
Q1 2025 May 15, 2025	BUY	$25.75 - $33.86 $4.56 Million - $5.99 Million	176,998 Added 6.72%	2,810,880 $87.5 Million
Q4 2024 Feb 13, 2025	SELL	$24.28 - $28.39 $11.6 Million - $13.6 Million	-478,679 Reduced 15.38%	2,633,882 $67.2 Million
Q3 2024 Feb 28, 2025	SELL	$25.63 - $29.27 $1.18 Million - $1.35 Million	-46,030 Reduced 1.75%	2,587,852 $73.2 Million

Q3 2024 Nov 14, 2024	BUY	$25.63 - $29.27 $835,281 - $953,909	32,590 Added 1.06%	3,112,561 $88.1 Million
Q2 2024 May 29, 2025	BUY	$26.26 - $29.9 $5.03 Million - $5.73 Million	191,625 Added 8.09%	2,560,429 $67.5 Million
Q2 2024 Aug 14, 2024	BUY	$26.26 - $29.9 $4.71 Million - $5.36 Million	179,206 Added 6.18%	3,079,971 $81.2 Million
Q1 2024 May 29, 2025	SELL	$27.46 - $31.33 $12.1 Million - $13.9 Million	-442,076 Reduced 15.73%	2,368,804 $71.9 Million
Q1 2024 May 14, 2024	SELL	$27.46 - $31.33 $509,520 - $581,328	-18,555 Reduced 0.64%	2,900,765 $88.1 Million
Q4 2023 May 29, 2025	SELL	$26.21 - $29.22 $11.4 Million - $12.8 Million	-436,829 Reduced 15.54%	2,374,051 $66.7 Million
Q4 2023 Feb 15, 2024	BUY	$26.21 - $29.22 $9.77 Million - $10.9 Million	372,682 Added 14.63%	2,919,320 $82 Million
Q3 2023 Nov 14, 2023	BUY	$26.26 - $31.38 $3.47 Million - $4.14 Million	132,008 Added 5.47%	2,546,638 $69.1 Million
Q2 2023 Aug 14, 2023	BUY	$29.6 - $36.56 $4.77 Million - $5.89 Million	161,230 Added 7.15%	2,414,630 $74.2 Million
Q1 2023 May 15, 2023	BUY	$32.77 - $39.4 $473,985 - $569,881	14,464 Added 0.65%	2,253,400 $81.2 Million
Q4 2022 Feb 14, 2023	SELL	$39.17 - $44.04 $1.51 Million - $1.7 Million	-38,661 Reduced 1.7%	2,238,936 $88.5 Million
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $1.77 Million - $1.98 Million	44,302 Added 1.98%	2,277,597 $91.5 Million
Q2 2022 Aug 22, 2022	BUY	$37.53 - $44.22 $4.07 Million - $4.8 Million	108,455 Added 5.1%	2,233,295 $93.9 Million
Q1 2022 May 16, 2022	BUY	$37.46 - $42.44 $10.6 Million - $12 Million	282,324 Added 15.32%	2,124,840 $82.8 Million
Q4 2021 Feb 14, 2022	BUY	$35.17 - $42.48 $12.2 Million - $14.8 Million	347,486 Added 23.24%	1,842,516 $73.4 Million
Q3 2021 Nov 15, 2021	BUY	$36.14 - $42.24 $859,879 - $1.01 Million	23,793 Added 1.62%	1,495,030 $54 Million
Q2 2021 Aug 12, 2021	BUY	$39.85 - $46.63 $2.74 Million - $3.2 Million	68,665 Added 4.9%	1,471,237 $60.3 Million
Q1 2021 May 17, 2021	BUY	$42.34 - $52.82 $39.3 Million - $49.1 Million	928,993 Added 196.16%	1,402,572 $61.2 Million
Q4 2020 Feb 12, 2021	BUY	$36.12 - $50.05 $16.2 Million - $22.4 Million	447,246 Added 1698.42%	473,579 $23.7 Million
Q3 2020 Nov 13, 2020	SELL	$38.56 - $48.36 $1.54 Million - $1.94 Million	-40,019 Reduced 60.31%	26,333 $1.11 Million
Q2 2020 Aug 14, 2020	BUY	$44.5 - $52.11 $2.95 Million - $3.46 Million	66,352 New	66,352 $3.22 Million

Others Institutions Holding RPRX

# of Institutions

534

Shares Held

304M

Call Options Held

1.34M

Put Options Held

252K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $17.1B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Royalty Pharma PLC Transaction History